Data‐driven neurocognitive surveillance and screening approaches in pediatric sickle cell disease

2025/12/12 by Jeffrey Karst, Meghan Miller
Medicine · #Hemoglobinopathies and Related Disorders #Artificial Intelligence in Healthcare and Education #Epilepsy research and treatment

paper · doi:10.1111/dmcn.70121

Abstract

This commentary is on the original article by Bills et al. on pages 916‐924 of this issue.

Related

• Neurocognitive risk in sickle cell disease: Utilizing neuropsychology services to manage cognitive symptoms and functional limitations
• The clinical spectrum of <scp>HbSC</scp> sickle cell disease‐not a benign condition
• A Multidisciplinary Health Care Team's Efforts to Improve Educational Attainment in Children With Sickle‐Cell Anemia and Cerebral Infarcts
• Reducing Health Care Disparities in Sickle Cell Disease: A Review
• Hydroxyurea treatment and neurocognitive functioning in sickle cell disease from school age to young adulthood